---
title: "Clinical Trial Components in NIH K Career Development Awards: Types, Sizes, and Implications"
id: "medrxiv-19-clinical-trial-components-of-nih-career-development-awards-supporting-the"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-19-clinical-trial-components-of-nih-career-development-awards-supporting-the"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.18.26363419v1?rss=1"
published_at: "2026-09-20T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Clinical Trial Components in NIH K Career Development Awards: Types, Sizes, and Implications
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-19-clinical-trial-components-of-nih-career-development-awards-supporting-the
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.18.26363419v1?rss=1)
- **Published At:** 2026-09-20T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This cross-sectional analysis examined NIH RePORTER abstracts for **K01**, **K08**, and **K23** awards funded in FY2024–2025 under funding opportunity announcements that were either **clinical trial (CT) Required** or **CT Optional**. - A rule-based classification of free-text abstracts categorized awards into five mutually exclusive trial-type groups: pilot/feasibility/proof-of-concept; efficacy/effectiveness; trial confirmed but type unclear; other (mechanistic, ancillary, phase I/II); or no trial-specific language identified. - Among 1,336 unique awards (1,051 CT Required; 285 CT Optional), 815 (61.0%) were classified as **pilot/feasibility/proof-of-concept** and 55 (4.1%) as **efficacy/effectiveness** studies. - An additional 204 awards (15.3%) had a confirmed trial where the trial type was unclear, 41 (3.1%) were categorized as other, and 221 (16.5%) included no trial-specific language in the abstract. - Within CT Required awards specifically, 730 (69.5%) were pilot/feasibility/proof-of-concept, indicating early-stage trial emphasis in required CT FOAs. - Sample size was explicitly reported and manually verified for 273 awards (20.4%); the median reported sample size was 60 participants (IQR 44–80), and 236 (86.4%) of those enrolled ≤100 participants. - The authors conclude that NIH K award–associated trials are generally small and early-stage, and they note that NIH’s decision to discontinue supporting trial costs for K awards could negatively affect the pipeline of future clinical trialists. - Data sources, competing interest statements, and data availability were reported: study data come from reporter.nih.gov; authors declared no competing interests. - Detailed trial-type definitions, the rule-based classification approach, and other methodological specifics were described in the manuscript; if additional specifics (e.g., full classification rules) are needed, the source should be consulted.
## Clinical Analysis & Structured Key Points
Clinical Trial Components of NIH Career Development Awards: Supporting the Nation's Future Trialists | medRxiv Skip to main content Clinical Trial Components of NIH Career Development Awards: Supporting the Nation's Future Trialists Catherine G Derington , Lilia Cervantes , Larry A Allen , Katy E Trinkley , Amy G Huebschmann , P. Michael Ho doi: https://doi.org/10.64898/2026.09.18.26363419 Catherine G Derington 1 University of Colorado School of Medicine; Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: catherine.derington{at}cuanschutz.edu Lilia Cervantes 2 University of Colorado; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Larry A Allen 2 University of Colorado; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Katy E Trinkley 2 University of Colorado; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Amy G Huebschmann 2 University of Colorado; Find this author on Google Scholar Find this author on PubMed Search for this author on this site P. Michael Ho 3 Kaiser Permanente Colorado Institute for Health Research Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract In 2027, the National Institutes of Health (NIH) will no longer support costs associated with clinical trials (CT) for career development (K) awards. NIH's CT definition encompasses many types of research, from early-stage pilot work through definitive studies. The types and sizes of trials K awardees conduct have not been described, which could inform ongoing policy changes relevant to the next generation of clinical trialists. We conducted a cross-sectional analysis of NIH RePORTER data to characterize the types and sizes of CTs supported by NIH K01, K08, and K23 awards funded in fiscal years 2024-2025 under a CT Required or CT Optional funding opportunity announcement (FOA), with non-missing abstract text. A rule-based classification scheme applied to free-text abstracts categorized each award into 5 mutually exclusive trial types: pilot/feasibility/proof-of-concept, efficacy/effectiveness, trial confirmed with type unclear, other (mechanistic, ancillary, or phase I/II), or no trial-specific language identified. Trial size was assessed among abstracts reporting an explicit, manually verified sample size. Of 1336 unique awards funded under CT Required (n=1051) or CT Optional (n=285) FOAs, 815 (61.0%) were classified as pilot, feasibility, or proof-of-concept studies, and 55 (4.1%) as efficacy or effectiveness studies; 204 (15.3%) had a confirmed trial of unclear type, 41 (3.1%) were other, and 221 (16.5%) had no trial-specific language. Among CT Required awards, 730 (69.5%) were pilot, feasibility, or proof-of-concept work. Among 273 awards (20.4%) with a verified sample size, the median was 60 participants (IQR, 44-80), with 236 (86.4%) enrolling ≤100 participants. Given these findings that CT within NIH K awards are generally small and early-stage, NIH's decision to no longer support trial costs may adversely affect the scientist development pipeline. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced are available online at reporter.nih.gov https://www.reporter.nih.gov Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license . Back to top Previous Next Posted September 20, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Clinical Trial Components of NIH Career Development Awards: Supporting the Nation's Future Trialists Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Clinical Trial Components of NIH Career Development Awards: Supporting the Nation's Future Trialists Catherine G Derington , Lilia Cervantes , Larry A Allen , Katy E Trinkley , Amy G Huebschmann , P. Michael Ho medRxiv 2026.09.18.26363419; doi: https://doi.org/10.64898/2026.09.18.26363419 Share This Article: Copy Citation Tools Clinical Trial Components of NIH Career Development Awards: Supporting the Nation's Future Trialists Catherine G Derington , Lilia Cervantes , Larry A Allen , Katy E Trinkley , Amy G Huebschmann , P. Michael Ho medRxiv 2026.09.18.26363419; doi: https://doi.org/10.64898/2026.09.18.26363419 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Health Policy Subject Areas All Articles Addiction Medicine (619) Allergy and Immunology (903) Anesthesia (334) Cardiovascular Medicine (4828) Dentistry and Oral Medicine (479) Dermatology (419) Emergency Medicine (651) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1633) Epidemiology (15974) Forensic Medicine (33) Gastroenterology (1206) Genetic and Genomic Medicine (7065) Geriatric Medicine (734) Health Economics (1066) Health Informatics (5060) Health Policy (1437) Health Systems and Quality Improvement (1775) Hematology (587) HIV/AIDS (1347) Infectious Diseases (except HIV/AIDS) (16307) Intensive Care and Critical Care Medicine (1174) Medical Education (671) Medical Ethics (155) Nephrology (727) Neurology (7291) Nursing (368) Nutrition (1084) Obstetrics and Gynecology (1243) Occupational and Environmental Health (1005) Oncology (3614) Ophthalmology (1055) Orthopedics (398) Otolaryngology (457) Pain Medicine (472) Palliative Medicine (139) Pathology (709) Pediatrics (1805) Pharmacology and Therapeutics (739) Primary Care Research (768) Psychiatry and Clinical Psychology (5919) Public and Global Health (9770) Radiology and Imaging (2432) Rehabilitation Medicine and Physical Therapy (1456) Respiratory Medicine (1250) Rheumatology (642) Sexual and Reproductive Health (773) Sports Medicine (579) Surgery (782) Toxicology (107) Transplantation (305) Urology (293)
## Related Clinical Research

- [Barriers to Primary Healthcare for the Rural Bangladeshi Elderly: A Social Ecological Model Review](https://medichelpline.com/clinical-feed/plos-one-19-using-the-social-ecological-model-to-identify-barriers-to-accessing-and-using.md)
- [Using Open-Source LLMs to Extract Natural History Study Data for Rare Disease Research](https://medichelpline.com/clinical-feed/medrxiv-21-llm-enabled-natural-history-study-analysis-to-support-rare-disease-research.md)
- [Meditation Practice and Long-Term Mortality in US Adults: Pooled NHIS Cohorts Analysis](https://medichelpline.com/clinical-feed/medrxiv-6-meditation-practice-and-long-term-mortality-in-us-adults-a-doubly-robust.md)
- [Jehovah’s Witnesses permit blood-derived products but keep ban on whole-blood transfusions](https://medichelpline.com/clinical-feed/stat-news-0-jehovah-s-witnesses-allow-blood-derived-products-but-keep-ban-on-whole-blood.md)
- [8-hour time-restricted eating yields greater weight loss but not consistent blood pressure benefits](https://medichelpline.com/clinical-feed/medical-news-today-0-16-8-intermittent-fasting-best-for-weight-loss-but-not-for-blood-pressure.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.